Shionogi & Co., Ltd. Overview
Pro stress-test →Shionogi & Co., Ltd. is a Japanese pharmaceutical company best known for developing Crestor. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. With a market capitalization of $15.4B and trailing twelve month revenue of $2.93B, Shionogi maintains a significant presence across Japanese and global pharmaceutical markets.
Strategic Profile
Pro stress-test →The company develops prescription drugs, over-the-counter drugs, and diagnostic products for therapeutic areas including metabolic disorders, pain/CNS, infectious diseases and cancer, and offers contract development and manufacturing facilities. Shionogi provides products and services in Japan, Europe, North America, and other regions, positioning itself as a diversified specialty and generic pharmaceutical manufacturer with global reach.
Competitive Landscape
Pro stress-test →Shionogi competes with companies including Chugai Pharmaceutical, Astellas Pharma, Cipla, Novartis, and Takeda Pharmaceutical. The company holds a strong position in Japan's pharmaceutical market but faces intense global competition from larger integrated pharma firms with broader pipelines and R&D capabilities.
Industry Context
Shionogi & Co., Ltd. operates in Pharmaceuticals and Healthcare.
Key facts
Founded: 1878 · Headquarters: Osaka, Japan · Employees: 4,959 · Revenue: $2.93B-$3.0B · Market cap: $15.4B-$19.4B